No Data
No Data
Express News | Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data From Phase 2 Trial in Second-Line Kras Mutant Mcrc
Craig-Hallum Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Maintains Target Price $8
Cardiff Oncology Analyst Ratings
Craig-Hallum Initiates Cardiff Oncology(CRDF.US) With Buy Rating, Announces Target Price $8
Express News | Cardiff Oncology : Craig-Hallum Initiates Coverage With Buy Rating and Target Price $8
Earnings Call Summary | Cardiff Oncology(CRDF.US) Q2 2024 Earnings Conference
No Data
No Data